Project Details
Description
Phase II Study of Pembrolizumab in Combination with Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/17 → 11/30/22 |
Funding
- BIG TEN CANCER RESEARCH CONSORTIUM
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.